ID

25902

Beschreibung

Study ID: 100571 (M138) Clinical Study ID: 100571 Study Title: Double-blind randomized study to evaluate the immunogenicity and reactogenicity of two different lots of GlaxoSmithKline Biologicals' inactivated hepatitis A vaccine containing 1440 EL.U of antigen per mL and injected according to a 0, 12 month schedule in healthy adult volunteers Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00291876 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 4 Study Recruitment Status: Completed Generic Name: Hepatitis A Vaccine, Inactivated Trade Name: Havrix Study Indication: Hepatitis A https://clinicaltrials.gov/ct2/show/NCT00291876

Link

https://clinicaltrials.gov/ct2/show/NCT00291876

Stichworte

  1. 23.08.17 23.08.17 -
  2. 26.09.17 26.09.17 -
Hochgeladen am

26. September 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION NON SERIOUS ADVERSE EVENTS NCT00291876

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION NON SERIOUS ADVERSE EVENTS NCT00291876

Study administration
Beschreibung

Study administration

Center
Beschreibung

Center

Datentyp

text

Alias
UMLS CUI [1,1]
C1301943
UMLS CUI [1,2]
C0600091
Date of Visit
Beschreibung

Date of Visit

Datentyp

date

Alias
UMLS CUI [1]
C1320303
Subject Number
Beschreibung

Subject Identifier

Datentyp

integer

Alias
UMLS CUI [1]
C2348585
NON-SERIOUS ADVERSE EVENTS
Beschreibung

NON-SERIOUS ADVERSE EVENTS

Has any non-serious adverse events occurred within one month (Day 0 to Day 29) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
Beschreibung

(Please report all serious adverse events only on the Serious Adverse Event (SAE) form).

Datentyp

text

Alias
UMLS CUI [1]
C1518404
NON-SERIOUS ADVERSE EVENTS
Beschreibung

NON-SERIOUS ADVERSE EVENTS

AE No.
Beschreibung

adverse event number

Datentyp

integer

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0449788
Description
Beschreibung

adverse event description

Datentyp

text

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0678257
For GSK
Beschreibung

comment

Datentyp

text

Alias
UMLS CUI [1]
C0947611
Local (administration site)
Beschreibung

adverse event location

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0450429
UMLS CUI [1,3]
C0205276
Non-administration site
Beschreibung

adverse event location2

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0877248
UMLS CUI [1,2]
C0450429
Date started
Beschreibung

adverse event start date

Datentyp

date

Alias
UMLS CUI [1]
C2697888
during immediate postvaccination period specified in protocol
Beschreibung

immediate post-vaccination reaction

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2697888
UMLS CUI [1,2]
C0687676
UMLS CUI [1,3]
C0042196
Date Stopped
Beschreibung

adverse event end date

Datentyp

date

Alias
UMLS CUI [1]
C2697886
Intensity
Beschreibung

adverse event intensity

Datentyp

integer

Alias
UMLS CUI [1]
C1710066
Causality In your opinion, did the vaccine possibly contribute to this AE?
Beschreibung

causality

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3641099
UMLS CUI [1,2]
C0877248
Adverse Event Outcome
Beschreibung

Adverse Event Outcome

Datentyp

text

Alias
UMLS CUI [1]
C1705586

Ähnliche Modelle

GSK Hepatitis A Vaccine ADDITIONAL VACCINATION NON SERIOUS ADVERSE EVENTS NCT00291876

Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Study administration
Center
Item
Center
text
C1301943 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Date of Visit
Item
Date of Visit
date
C1320303 (UMLS CUI [1])
Subject Identifier
Item
Subject Number
integer
C2348585 (UMLS CUI [1])
Item Group
NON-SERIOUS ADVERSE EVENTS
Item
Has any non-serious adverse events occurred within one month (Day 0 to Day 29) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
text
C1518404 (UMLS CUI [1])
Code List
Has any non-serious adverse events occurred within one month (Day 0 to Day 29) post-vaccination, excluding those recorded on the Solicited Adverse Events pages?
CL Item
No (No)
CL Item
Yes, please complete the following table. (Yes, please complete the following table.)
Item Group
NON-SERIOUS ADVERSE EVENTS
adverse event number
Item
AE No.
integer
C0877248 (UMLS CUI [1,1])
C0449788 (UMLS CUI [1,2])
adverse event description
Item
Description
text
C0877248 (UMLS CUI [1,1])
C0678257 (UMLS CUI [1,2])
comment
Item
For GSK
text
C0947611 (UMLS CUI [1])
adverse event location
Item
Local (administration site)
boolean
C0877248 (UMLS CUI [1,1])
C0450429 (UMLS CUI [1,2])
C0205276 (UMLS CUI [1,3])
adverse event location2
Item
Non-administration site
boolean
C0877248 (UMLS CUI [1,1])
C0450429 (UMLS CUI [1,2])
adverse event start date
Item
Date started
date
C2697888 (UMLS CUI [1])
immediate post-vaccination reaction
Item
during immediate postvaccination period specified in protocol
boolean
C2697888 (UMLS CUI [1,1])
C0687676 (UMLS CUI [1,2])
C0042196 (UMLS CUI [1,3])
adverse event end date
Item
Date Stopped
date
C2697886 (UMLS CUI [1])
Item
Intensity
integer
C1710066 (UMLS CUI [1])
Code List
Intensity
CL Item
1 (1)
CL Item
2 (2)
CL Item
3 (3)
causality
Item
Causality In your opinion, did the vaccine possibly contribute to this AE?
boolean
C3641099 (UMLS CUI [1,1])
C0877248 (UMLS CUI [1,2])
Item
Adverse Event Outcome
text
C1705586 (UMLS CUI [1])
Code List
Adverse Event Outcome
CL Item
Recovered (1)
CL Item
Recovered with sequelae (2)
CL Item
Ongoing at subject study conclusion (3)
CL Item
Died (4)
CL Item
Unknown (5)
CL Item
fatal (6)

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video